(MD+DI) – Johnson & Johnson is offering a preview of its surgical robotics strategy May 13th during its Medical Device Business Review Day in New York. Executives of the New Brunswick, NJ-based company announced the date during a call discussing its 4Q19 results on Wednesday. […]
Dedicated to shaping the next frontier of surgery, Johnson & Johnsoni (NYSE: JNJ) today announced an agreement to acquire the remaining stake in Verb Surgical Inc. following a successful strategic collaboration with Verily, an Alphabet company. […]
Verb Surgical Inc. today announced that Kurt Azarbarzin has joined the company as President and Chief Executive Officer, effective immediately. […]
(MedTech Strategist) – J&J’s recent blockbuster deal for Auris is really just the latest in a series of moves the diversified market giant has made in positioning itself in the exploding field of robotically-enabled surgery. From Verb, its joint venture with Verily, to Orthotaxy to, now, Auris, J&J is developing and advancing what the company calls “a comprehensive digital surgery experience.” […]
(Motley Fool) – J&J’s latest acquisition might appear to threaten its partnership with Alphabet to develop robotic surgical systems. But another player could be affected even more. […]
Focused on creating the next frontier of surgery, Johnson & Johnson (NYSE: JNJ), today announced that Ethicon, Inc., entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4 billion in cash. […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes